Also, a mere extraction of overall quantitative features like the PSMA-positive total tumor volume might give a summary of the general prostate cancer development but does not account for varying cancer evolution patterns in the different organs, which can be especially important after a combination of systemic and local therapy. This evidence concerns the gene FOLH1 and neoplasm.